UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G/A

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

Protagonist Therapeutics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.00001 per share

(Title of Class of Securities)

 

74366E 102

(CUSIP Number)

 

December 31, 2019

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
Venrock Healthcare Capital Partners II, L.P.
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
PN

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

2

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
VHCP Co-Investment Holdings II, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

3

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
Venrock Healthcare Capital Partners III, L.P.
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
PN

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

4

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
VHCP Co-Investment Holdings III, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

5

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
VHCP Management II, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

6

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
VHCP Management III, LLC
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
Delaware

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
OO

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

7

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
Shah, Nimish
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
United States

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
IN

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

8

 

 

CUSIP No. 74366E 102

 

 
  1. Name of Reporting Persons
Koh, Bong
 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) x(1)
    (b) o
 
  3. SEC Use Only
 
  4. Citizenship or Place of Organization
United States

 

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5. Sole Voting Power
0
 
6. Shared Voting Power
113,140(2)
 
7. Sole Dispositive Power
0
 
8. Shared Dispositive Power
113,140(2)

 

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
113,140(2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
 
  11. Percent of Class Represented by Amount in Row (9)
0.4%(3)
 
  12. Type of Reporting Person (See Instructions)
IN

 

 

(1)Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

 

(2)Consists of 22,922 shares owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares owned by VHCP Co-Investment Holdings III, LLC.

 

(3)This percentage is calculated based upon 27,206,447 shares of the Issuer’s common stock outstanding as of September 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2019.

 

9

 

 

 

 

CUSIP No. 74366E 102

 

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III” and collectively with VHCP II LP, VHCP Co-Investment II, VHCP III LP, VHCP Co-Investment III and VHCP Management II, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of Common Stock of Protagonist Therapeutics, Inc.

  

Item 1.
  (a) Name of Issuer
Protagonist Therapeutics, Inc.
  (b) Address of Issuer’s Principal Executive Offices
7707 Gateway Boulevard, Suite 140
Newark, California 94560
 
Item 2.
  (a) Name of Person Filing
Venrock Healthcare Capital Partners II, L.P.  
VHCP Co-Investment Holdings II, LLC  
Venrock Healthcare Capital Partners III, L.P.  
VHCP Co-Investment Holdings III, LLC  
VHCP Management II, LLC  
VHCP Management III, LLC  
Nimish Shah  
Bong Koh  
  (b) Address of Principal Business Office or, if none, Residence
    New York Office:  
7 Bryant Park
23rd Floor
New York, NY 10018  
Palo Alto Office:  
3340 Hillview Avenue
Palo Alto, CA 94304  

       
  (c) Citizenship
All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.
  (d) Title of Class of Securities
Common Stock, par value $0.00001 per share

 

  (e) CUSIP Number
74366E 102

  

10

 

  

CUSIP No. 74366E 102
 
Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
   
Not applicable
   
Item 4. Ownership
  (a) Amount Beneficially Owned as of December 31, 2019:

 

Venrock Healthcare Capital Partners II, L.P.   113,140 (1)
VHCP Co-Investment Holdings II, LLC   113,140 (1)
Venrock Healthcare Capital Partners III, L.P.   113,140 (1)
VHCP Co-Investment Holdings III, LLC   113,140 (1)
VHCP Management II, LLC   113,140 (1)
VHCP Management III, LLC   113,140 (1)
Nimish Shah   113,140 (1)
Bong Koh   113,140 (1)

 

 

 (b)  

 

Percent of Class as of December 31, 2019:  

 

Venrock Healthcare Capital Partners II, L.P.   0.4 %
VHCP Co-Investment Holdings II, LLC   0.4 %
Venrock Healthcare Capital Partners III, L.P.   0.4 %
VHCP Co-Investment Holdings III, LLC   0.4 %
VHCP Management II, LLC   0.4 %
VHCP Management III, LLC   0.4 %
Nimish Shah   0.4 %
Bong Koh   0.4 %

 

 

(c)  

 

Number of shares as to which the person has, as of December 31, 2019:

     

    (i) Sole power to vote or to direct the vote

 

Venrock Healthcare Capital Partners II, L.P.   0  
VHCP Co-Investment Holdings II, LLC   0  
Venrock Healthcare Capital Partners III, L.P.   0  
VHCP Co-Investment Holdings III, LLC   0  
VHCP Management II, LLC   0  
VHCP Management III, LLC   0  
Nimish Shah   0  
Bong Koh   0  

   

 

11

 

  

CUSIP No. 74366E 102
    (ii) Shared power to vote or to direct the vote

 

 

Venrock Healthcare Capital Partners II, L.P.   113,140 (1)
VHCP Co-Investment Holdings II, LLC   113,140 (1)
Venrock Healthcare Capital Partners III, L.P.   113,140 (1)
VHCP Co-Investment Holdings III, LLC   113,140 (1)
VHCP Management II, LLC   113,140 (1)
VHCP Management III, LLC   113,140 (1)
Nimish Shah   113,140 (1)
Bong Koh   113,140 (1)

    (iii) Sole power to dispose or to direct the disposition of

 

 

Venrock Healthcare Capital Partners II, L.P.   0  
VHCP Co-Investment Holdings II, LLC   0  
Venrock Healthcare Capital Partners III, L.P.   0  
VHCP Co-Investment Holdings III, LLC   0  
VHCP Management II, LLC   0  
VHCP Management III, LLC   0  
Nimish Shah   0  
Bong Koh   0  

    (iv) Shared power to dispose or to direct the disposition of

 

 

Venrock Healthcare Capital Partners II, L.P.   113,140 (1)
VHCP Co-Investment Holdings II, LLC   113,140 (1)
Venrock Healthcare Capital Partners III, L.P.   113,140 (1)
VHCP Co-Investment Holdings III, LLC   113,140 (1)
VHCP Management II, LLC   113,140 (1)
VHCP Management III, LLC   113,140 (1)
Nimish Shah   113,140 (1)
Bong Koh   113,140 (1)

       

 

(1) These shares are owned directly as follows: 22,922 shares are owned by Venrock Healthcare Capital Partners II, L.P., 9,289 shares are owned by VHCP Co-Investment Holdings II, LLC, 73,577 shares are owned by Venrock Healthcare Capital Partners III, L.P. and 7,352 shares are owned by VHCP Co-Investment Holdings III, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. Messrs. Shah and Koh are the voting members of VHCP Management II, LLC and VHCP Management III, LLC.

 

Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.  
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable  

 

12

 

  

CUSIP No. 74366E 102
 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
   
Not Applicable  
 
Item 8. Identification and Classification of Members of the Group
   
Not Applicable  
 
Item 9. Notice of Dissolution of a Group
   
Not Applicable  
 
Item 10. Certification
   
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.  

  

13

 

  

CUSIP No. 74366E 102

 

SIGNATURE

  

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2020

 

   
Venrock Healthcare Capital Partners II, L.P. Venrock Healthcare Capital Partners III, L.P.
   
By: VHCP Management II, LLC By: VHCP Management III, LLC
Its: General Partner Its: General Partner
   
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory   Its: Authorized Signatory
   
VHCP Co-Investment Holdings II, LLC VHCP Co-Investment Holdings III, LLC
   
By: VHCP Management II, LLC By: VHCP Management III, LLC
Its: Manager Its: Manager
   
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory   Its: Authorized Signatory
   
VHCP Management II, LLC VHCP Management III, LLC
   
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  Name: David L. Stepp     Name: David L. Stepp
  Its: Authorized Signatory   Its: Authorized Signatory

   
Nimish Shah Bong Koh
   
By: /s/ David L. Stepp   By: /s/ David L. Stepp
  David L. Stepp, as attorney-in-fact   David L. Stepp, as attorney-in-fact
         

 

14

 

 

CUSIP No. 74366E 102

 

EXHIBITS

 

A: Joint Filing Agreement (incorporated by reference to Exhibit A to the Schedule 13G filed with the Securities and Exchange Commission on June 17, 2019)

 

B: Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to the Schedule 13G filed with the Securities and Exchange Commission on June 17, 2019)

  

C: Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to the Schedule 13G filed with the Securities and Exchange Commission on June 17, 2019)

 

15